MNKD.NASDAQMannkind CORP

Form 4: MannKind Corp Director Anthony Hooper Reports Acquisition of Shares and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Anthony Hooper reports acquiring 25,000 shares of MannKind Corp common stock and restricted stock units.

Summary

  • On May 14, 2025, Anthony Hooper, a director of MannKind Corp, acquired 25,000 shares of common stock at a price of $4.56 per share through the Issuer's Market Price Stock Purchase Plan.
  • The purchase was approved by the Company's Board of Directors on the same day.
  • Hooper also acquired 52,854 restricted stock units (RSUs) that vested on May 14, 2025, but the shares will not be delivered until separation of service from the board.
  • Additionally, Hooper acquired 10,571 RSUs in lieu of an annual cash retainer payment, which vest immediately, but the shares will also be delivered upon separation of service.
  • Following these transactions, Hooper directly owns 201,153 shares of common stock and 63,425 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider trading activity. The director's purchase could be seen as slightly positive, but it's not a strong signal.

Positives

  • A director's purchase of shares may signal confidence in the company's future.
  • The granting of RSUs in lieu of cash may indicate a desire to conserve cash resources.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. They are closely watched by investors for signals about management's confidence in the company.

Comparison to Industry Standards

  • Insider transactions are common across publicly traded companies, and the details of these transactions (e.g., purchase price, number of shares) are specific to the individual and the company's stock performance.
  • Comparing Hooper's transactions to those of other directors in similar pharmaceutical companies would require analyzing their Form 4 filings and considering factors such as company size, stock performance, and compensation structure.

Stakeholder Impact

  • Shareholders may view the director's stock purchase as a positive sign.
  • The use of RSUs instead of cash for compensation could benefit the company's financial position.

Key Dates

DateDescription
May 13, 2023Effective date of the Issuer's Market Price Stock Purchase Plan
May 14, 2025Date of transaction, board approval, and vesting of RSUs
May 16, 2025Date of signature

Keywords

Form 4, MNKD, MannKind Corp, Director, Anthony Hooper, Stock Purchase, Restricted Stock Units, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.